Leah Buletti

A new drug targeting triple-negative breast cancer overwhelms cancer cells with fat-like molecules called ceramides.

Sylvester is launching a 12-week lifestyle medicine program to support safe weight loss for cancer survivors.

Rosa Rademakers, Ph.D., a neurogeneticist whose work at Mayo Clinic led to a landmark finding in neurodegenerative disease, has been awarded the 2026 Breakthrough Prize in Life Sciences for the discovery of the most common genetic cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), which charted the path for new mechanistic studies of these diseases.

A $114,000 grant is funding a self-guided, web-based survivorship program for people with HPV‑related head and neck cancer.

For more than six years, the University of Miami Health System has delivered adaptive radiation therapy, using daily imaging to adjust treatment plans in real time for greater precision.

Mayo Clinic researchers developed an experimental nanotherapy that delivers two cancer drugs directly to brain tumors.

Researchers found that metformin raises levels of a natural molecule linked to exercise in men with prostate cancer, even when they aren’t physically active.

For students curious about science, medicine and the fight against cancer, Moffitt Cancer Center is offering more than just exposure. It is creating meaningful pathways into the world of cancer research.

A five-year, multisite Mayo Clinic study finds high diagnostic accuracy, low complication rates — and a shift toward earlier-stage detection.

UF Health was honored with the American Cancer Society’s Health System Partner of the Year award.